| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10897383 | Cancer Epidemiology | 2013 | 4 Pages |
Abstract
The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Paige Wartko, Mark E. Sherman, Hannah P. Yang, Ashley S. Felix, Louise A. Brinton, Britton Trabert,